Can a walking program with text reminders and social support boost health in adults with intellectual disabilities?
NCT ID NCT04573530
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a program called We Walk Plus, which uses a Fitbit activity tracker, personalized text messages, and a private social network to encourage walking in 46 adults aged 35-60 with mild or moderate intellectual disabilities. The goal is to see if the program is feasible and acceptable, and whether it can increase daily steps and improve cognition. Participants will wear the Fitbit, receive SMS reminders, and connect with others in a private online community.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- We Walk Plus intervention (personalized SMS, Fitbit activity monitor, private social network)
- What this could lead to
- If successful, this could point toward a simple, low-cost way to help older adults with intellectual disabilities become more active and potentially improve their thinking skills.
- What could go wrong
- This is a small feasibility study with only 46 participants, so results may not apply to everyone. The program relies on support from family or staff, which may limit its use in other settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTELLECTUAL DISABILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Trinity Services Inc.
New Lenox, Illinois, 60451, United States
-
University of Illinois at Chicago
Chicago, Illinois, 60608, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mapping a rare Gene's effects pave the way to targeted epilepsy therapies?
- Massive global registry aims to unlock secrets of rett syndrome
- New DNA tests could spot hidden chromosome flaws in infertility and developmental disorders
- Massive gene hunt aims to solve mystery of intellectual disability
- AI tablet rehab gets a Kid-Friendly makeover
- New therapy aims to tame emotional meltdowns in kids with autism and intellectual disability